author-photo

Bin Zhou

Novavax

21

Papers

788

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination.

2021
Show All
- Source
- Cite
- Save
Citations (6)
Combination Respiratory Vaccine Containing Recombinant SARS-CoV-2 Spike and Quadrivalent Seasonal Influenza Hemagglutinin Nanoparticles with Matrix-M Adjuvant

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (3)
Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (17)
Collaboration between the Fab and Fc Contribute to Maximal Protection Against SARS-CoV-2 Following NVX-CoV2373 Subunit Vaccine with Matrix-M™ Vaccination

2021 Social Science Research Network
Show All
- Source
- Cite
- Save
Citations (1)
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 elicits immunogenicity in baboons and protection in mice

2020 bioRxiv
Show All
- Source
- Cite
- Save
Citations (57)
Induction of Cross-reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-cell Responses by a Recombinant Matrix-M-Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine.

2020 Clinical Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (7)
Influenza Hemagglutinin Nanoparticle Vaccine Elicits Broadly Neutralizing Antibodies against Structurally Distinct Domains of H3N2 HA

2020 Vaccine
Show All
- Source
- Cite
- Save
Citations (16)
Comparison of the Safety and Immunogenicity of a Novel Matrix-M-adjuvanted Nanoparticle Influenza Vaccine with a Quadrivalent Seasonal Influenza Vaccine in Older Adults: A Randomized Controlled Trial

2020 medRxiv
Show All
- Source
- Cite
- Save
Citations (5)
2753. Induction of Broadly Cross-Reactive Immune Responses Against A(H3N2) Airuses: Results of a Phase 2 Trial of a Novel Recombinant Hemagglutinin Saponin-Adjuvanted Nanoparticle Seasonal Influenza Vaccine

2019 Open Forum Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes

2017 Vaccine
Show All
- Source
- Cite
- Save
Citations (26)